Stephen Colbert Condemns Trump’s Digging for Dirt During a War

Kao USA Expands Recall Of Jergens Ultra Healing Moisturizer

Kao USA Inc. has expanded its recall of Jergens Ultra Healing Moisturizer due to the presence of Pluralibacter gergoviae, a bacterium, the U.S. Food and Drug Administration announced.

The latest recall adds two lot codes to its earlier announced recall of Jergens Ultra Healing Moisturizer 3 oz and 10 oz products.

Lot codes ZU722861 and ZU722871 have been added to 3 oz size section of the moisturizer, along with earlier announced codes of ZU712851, ZU712861, ZU712871, ZU712881, ZU712911, ZU722851, and ZU722881.

As announced earlier, the affected lot codes for the 10 oz size include ZU722741, ZU722771, ZU722781, ZU732781, ZU732791, ZU732801, ZU732811, and ZU732821.

Jergens Ultra Healing Moisturizer was manufactured between October 1 and October 18, 2021.

The recall was initiated after the company determined that select units of Jergens Moisturizer could show the presence of Pluralibacter gergoviae.

The bacterium typically poses little medical risk to healthy people. However, people who have certain health problems such as weakened immune systems may be more susceptible to infections.

Kao USA urged consumers to discontinue use of the recalled lotion. Further investigation to determine the scope of the issue is still ongoing.

Deutsche Wohnen FY21 Earnings Drop

Deutsche Wohnen AG (DWHHF.PK), a German property company, on Thursday posted a decline in its earnings for the fiscal 2021, citing decreased disposals activity, goodwill amortization, fair value adjustments of convertible bonds, and transaction-related one-off costs in connection with the merger of Vonovia SE.

The company’s Funds From Operations also fell slightly for the year.

For the fiscal 2021, the property firm reported a post tax-profit of 919 million euros, compared with 1.55 billion euros, reported a year ago.

The Group registered its earnings before taxes of 1.77 billion euros as against 2.25 billion euros, reported for the previous year.

In line with its previous projections, the company reported an FFO of 1.54 euros per share, a fall of 0.6 percent, compared with the previous year.

For the 12-month period, Deutsche Wohnen generated an EBITDA of 634.68 million euros versus, 686.7 million euros, on year-on-year basis.

The company posted a decline in its earnings from disposals for the period at 2 million euros, compared with 20.4 million euros of last year.

Looking ahead, for the fiscal 2022, Deutsche Wohnen expects an FFO of 490 million euros.

Air China Posts Wider Loss In 2021

Air China Ld (AIRC.L,AIRYY.PK) posted a loss to equity shareholders of RMB 16.6 billion for the year ended 31 December 2021 compared to a loss of RMB 14.4 billion, prior year. Loss per share in cents was 121.12 compared to a loss of RMB 104.87. Fiscal year revenue increased to RMB 74.53 billion from RMB 69.50 billion, prior year.

No dividend was paid or proposed for ordinary shareholders during 2021, nor has any dividend been proposed since the end of the reporting period.

GERRY WEBER Preliminary FY21 Earnings Significantly Exceeds Original Forecast

GERRY WEBER Group (GRYIF.PK) reported preliminary fiscal 2021 normalized consolidated EBITDA excluding the effects of lease accounting under IFRS 16 to be between 25 million euros and 30 million euros, significantly exceeding the original forecast of a negative low double-digit million figure. The company noted that, even without the recognition of the interim state aid III, EBITDA excluding the effects of lease accounting under IFRS 16 will exceed the original forecast of a negative low double-digit million figure.

Based on preliminary figures, the company generated consolidated sales at the lower forecast range of 260 million euros and 280 million euros in fiscal 2021, meeting its guidance.

Tate & Lyle To Buy Chinese Dietary Fibre Business For $237 Mln In Cash – Quick Facts

Tate & Lyle PLC (TATE.L,TATYY.PK), a supplier of food and beverage ingredients, announced Thursday that it has signed an agreement to acquire China’s Quantum Hi-Tech (Guangdong) Biological Co., Ltd from ChemPartner Pharmatech Co., Ltd for a total cash consideration of $237 million.

The company expects to complete the acquisition in the second quarter of 2022 calendar year, subject to approval by the shareholders of ChemPartner.

The acquisition is expected to be accretive to revenue growth and EBITDA margin for Tate & Lyle in the first year of ownership.

Quantum Hi-Tech is a prebiotic dietary fibre business in China. For the 11 months ended November 30, 2021, Quantum generated revenue of $46 million and EBITDA of $14 million.

Tate & Lyle said the deal will significantly strengthen its position dietary fibres, and extend its presence and customer offering in China and Asia.

Quantum produces its range of FOS and GOS fibres at its production site in Guangdong Province, Southern China. The management team of Quantum will join Tate & Lyle at completion.

Nick Hampton, Chief Executive at Tate & Lyle, said, “The acquisition is also very much in line with our purpose to support healthy living by improving gut health, and driving sugar and calorie reduction and fibre fortification for consumers across the world.”

Stephen Colbert Condemns Trump’s Digging for Dirt During a War

“It’s generally frowned upon for U.S. presidents, current or former, to solicit our murderous mortal enemies for dirt on their political rivals,” Colbert said.

Send any friend a story

As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share.

By Trish Bendix